申请人:Axikin Pharmaceuticals, Inc.
公开号:US08916555B2
公开(公告)日:2014-12-23
Provided herein are 3,5-diaminopyrazoles, for example, compounds of Formula IA, that are useful for modulating regulated-in-COPD kinase activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RC kinase-mediated disorder, disease, or condition.
本文提供了3,5-二氨基吡唑,例如,公式IA的化合物,用于调节调节性慢性阻塞性肺病激酶活性及其制药组合物。本文还提供了使用它们治疗、预防或改善RC激酶介导的紊乱、疾病或症状的方法。